280 related articles for article (PubMed ID: 29235250)
1. Discovery and Mechanistic Elucidation of a Class of Protein Disulfide Isomerase Inhibitors for the Treatment of Glioblastoma.
Kyani A; Tamura S; Yang S; Shergalis A; Samanta S; Kuang Y; Ljungman M; Neamati N
ChemMedChem; 2018 Jan; 13(2):164-177. PubMed ID: 29235250
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genes.
Xu S; Liu Y; Yang K; Wang H; Shergalis A; Kyani A; Bankhead A; Tamura S; Yang S; Wang X; Wang CC; Rehemtulla A; Ljungman M; Neamati N
Theranostics; 2019; 9(8):2282-2298. PubMed ID: 31149044
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.
Yang S; Shergalis A; Lu D; Kyani A; Liu Z; Ljungman M; Neamati N
J Med Chem; 2019 Apr; 62(7):3447-3474. PubMed ID: 30759340
[TBL] [Abstract][Full Text] [Related]
4. Activation of the Unfolded Protein Response via Inhibition of Protein Disulfide Isomerase Decreases the Capacity for DNA Repair to Sensitize Glioblastoma to Radiotherapy.
Liu Y; Ji W; Shergalis A; Xu J; Delaney AM; Calcaterra A; Pal A; Ljungman M; Neamati N; Rehemtulla A
Cancer Res; 2019 Jun; 79(11):2923-2932. PubMed ID: 30996048
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Aminobenzylphenols as Protein Disulfide Isomerase Inhibitors in Glioblastoma Cell Lines.
Shergalis A; Xue D; Gharbia FZ; Driks H; Shrestha B; Tanweer A; Cromer K; Ljungman M; Neamati N
J Med Chem; 2020 Sep; 63(18):10263-10286. PubMed ID: 32830969
[TBL] [Abstract][Full Text] [Related]
6. ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors.
Duncan RM; Reyes L; Moats K; Robinson RM; Murphy SA; Kaur B; Stessman HAF; Dolloff NG
Cancer Res; 2020 Aug; 80(16):3279-3291. PubMed ID: 32561529
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway.
Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L
Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283
[TBL] [Abstract][Full Text] [Related]
8. Tuning isoform selectivity and bortezomib sensitivity with a new class of alkenyl indene PDI inhibitor.
Robinson RM; Reyes L; Duncan RM; Bian H; Strobel ED; Hyman SL; Reitz AB; Dolloff NG
Eur J Med Chem; 2020 Jan; 186():111906. PubMed ID: 31787362
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of protein disulfide isomerase inhibitors with nitric oxide releasing activity.
Li L; Liu J; Ding Y; Shi Z; Peng B; Yang N; Hong D; Zhang C; Yao C; Ge J; Huang W
Bioorg Med Chem Lett; 2020 Feb; 30(3):126898. PubMed ID: 31874828
[TBL] [Abstract][Full Text] [Related]
10. Targeting unfolded protein response using albumin-encapsulated nanoparticles attenuates temozolomide resistance in glioblastoma.
Kiang KM; Tang W; Song Q; Liu J; Li N; Lam TL; Shum HC; Zhu Z; Leung GK
Br J Cancer; 2023 May; 128(10):1955-1963. PubMed ID: 36927978
[TBL] [Abstract][Full Text] [Related]
11. Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma.
Vatolin S; Phillips JG; Jha BK; Govindgari S; Hu J; Grabowski D; Parker Y; Lindner DJ; Zhong F; Distelhorst CW; Smith MR; Cotta C; Xu Y; Chilakala S; Kuang RR; Tall S; Reu FJ
Cancer Res; 2016 Jun; 76(11):3340-50. PubMed ID: 27197150
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Neuroblastoma Cells with Inhibitors of Protein Disulfide Isomerase Upregulates NQO1 Activity.
Özcelik D
Chem Res Toxicol; 2020 Aug; 33(8):2099-2107. PubMed ID: 32662633
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of protein disulfide isomerase P5 in glioblastoma cells as a novel anticancer target.
Horibe T; Torisawa A; Masuda Y; Kawakami K
Oncol Rep; 2019 Feb; 41(2):961-972. PubMed ID: 30431130
[TBL] [Abstract][Full Text] [Related]
14. Discovery of protein disulfide isomerase P5 inhibitors that reduce the secretion of MICA from cancer cells.
Horibe T; Torisawa A; Okuno Y; Kawakami K
Chembiochem; 2014 Jul; 15(11):1599-606. PubMed ID: 24920482
[TBL] [Abstract][Full Text] [Related]
15. A small molecule inhibits protein disulfide isomerase and triggers the chemosensitization of cancer cells.
Eirich J; Braig S; Schyschka L; Servatius P; Hoffmann J; Hecht S; Fulda S; Zahler S; Antes I; Kazmaier U; Sieber SA; Vollmar AM
Angew Chem Int Ed Engl; 2014 Nov; 53(47):12960-5. PubMed ID: 25256790
[TBL] [Abstract][Full Text] [Related]
16. HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases.
Kung PH; Hsieh PW; Lin YT; Lee JH; Chen IH; Wu CC
Redox Biol; 2017 Oct; 13():266-277. PubMed ID: 28600983
[TBL] [Abstract][Full Text] [Related]
17. Thioredoxin-interacting protein regulates protein disulfide isomerases and endoplasmic reticulum stress.
Lee S; Min Kim S; Dotimas J; Li L; Feener EP; Baldus S; Myers RB; Chutkow WA; Patwari P; Yoshioka J; Lee RT
EMBO Mol Med; 2014 Jun; 6(6):732-43. PubMed ID: 24843047
[TBL] [Abstract][Full Text] [Related]
18. Protein disulfide isomerase: a promising target for cancer therapy.
Xu S; Sankar S; Neamati N
Drug Discov Today; 2014 Mar; 19(3):222-40. PubMed ID: 24184531
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic Reticulum Protein Disulfide Isomerase Shapes T Cell Efficacy for Adoptive Cellular Therapy of Tumors.
Hurst KE; Lawrence KA; Reyes Angeles L; Ye Z; Zhang J; Townsend DM; Dolloff N; Thaxton JE
Cells; 2019 Nov; 8(12):. PubMed ID: 31779147
[TBL] [Abstract][Full Text] [Related]
20. Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment.
Xu S; Butkevich AN; Yamada R; Zhou Y; Debnath B; Duncan R; Zandi E; Petasis NA; Neamati N
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16348-53. PubMed ID: 22988091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
